25 min listen
Phase 2 Trial of a Novel COPD Treatment
Phase 2 Trial of a Novel COPD Treatment
ratings:
Length:
27 minutes
Released:
May 1, 2015
Format:
Podcast episode
Description
Drs. Stephen Rennard and Shawn Aaron discuss a manuscript from Dr. Rennard and his colleagues about using the CXCR2 antagonist MK-7123 to improve lung function in COPD. The podcast is moderated by AJRCCM podcast editor, Nitin Seam.
Released:
May 1, 2015
Format:
Podcast episode
Titles in the series (100)
COPD exacerbations and increased cardiovascular risk: Dr. Nitin Seam speaks with Dr. Anant Patel and Dr. Mark Dransfield by Out of the Blue: An AJRCCM Podcast